Share Name Share Symbol Market Type Share ISIN Share Description
Silence Ther. LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75p -0.88% 84.75p 84.50p 85.00p 84.75p 84.50p 84.75p 19,827.00 12:09:46
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 -10.4 -12.1 - 45.03

Silence Therapeutics Share Discussion Threads

Showing 49976 to 50000 of 50000 messages
Chat Pages: 2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  Older
DateSubjectAuthorDiscuss
21/4/2017
09:26
Sorry not a holder here but OT Callumross,I notice you were in the old Armour group that is now ONEVIEW did you stay in them through the transition can I ask? Are they a completely different animal because it looks like it?
hazl
19/4/2017
16:15
A lot of buying interest over the last few days 1gw. Forget that they are recorded as sells. You have been able to buy at less than mid price for weeks. It's a slow burner, this one, but patience will be rewarded.
callumross
18/4/2017
15:33
Well, my decision to follow Silence into Arrowhead has proved to be a rather poor one so far. Still, patient capital and all that...
1gw
28/3/2017
08:32
Callum,don't follow that closely but regardless does anyone see much real progress?
waterloo01
28/3/2017
08:29
Waterloo - it has been known that ATU027 has effectively been sidelined for over a year.
callumross
28/3/2017
07:19
So little real progress, actually some in reverse (note Aut 027, the big hope has been effectively killed off). Hopes that investment in Arrowhead has more success. poor all round IMO.
waterloo01
28/3/2017
07:16
Certainly confident: "...the Directors believe that the totality of our IP alone represents a very significant risk/reward upside relative to the market cap and enterprise value of Silence."
1gw
27/3/2017
16:07
Feverish trading ahead of tomorrow's results I see...
1gw
24/3/2017
13:01
Is this a poison pill adopted by Arrowhead? "The rights will be exercisable only if a person or group acquires 15% or more of the company’s outstanding common stock." hTtps://uk.finance.yahoo.com/news/arrowhead-pharmaceuticals-adopts-stockholder-rights-113000141.html
1gw
20/3/2017
10:52
Roll on the results so we can see the numbers and the company spin on the outlook and see if there was anything to justify the selling.
1gw
20/3/2017
10:33
One weekend later ,i can see i was wrong !!.
partner
16/3/2017
13:24
I have said this before ,but was that the overhang of our seller finally cleared yesterday ?.
partner
16/3/2017
10:45
Sign of life in the old dog at last?
callumross
15/3/2017
07:59
Nice late reported trade from yesterday, over 1million shares sold / purchased again.
partner
13/3/2017
07:43
Our opinion is a 200p+ stock price correct. V real poss tie up with ARWR in the med term too.
richie666
13/3/2017
07:42
cheers for the BUY Richie... been a dull hold for now as you say in the note, the mkt cap is tiny for all the IP and knowledge that SLN has built up over the years.
maccamcd
13/3/2017
07:19
New Conviction Buy recomm just out - http://www.alignresearch.co.uk/silence-therapeutics/new-conviction-buy-stance/
richie666
28/2/2017
14:47
And just for good measure I've taken some in Arrowhead directly today.
1gw
27/2/2017
15:53
In fact I've convinced myself. So that's me buying some more at a bit under 93p. Edit - and I see it has been marked up as a sell!
1gw
27/2/2017
15:48
And although the Arrowhead price has been fairly volatile, at $2.31 just now I make that a 40% return on Silence's announced investment ($1.65 average purchase price by my calcs). Perhaps we should petition Ali to take a few more of these strong-conviction punts?
1gw
27/2/2017
15:32
Arrowhead: +7% today Silence: -7% today Surely some arbitrage potential here... ...unless perhaps the reason for the disparity is that someone's worked out that Silence is building its position and so is already playing the arb?
1gw
22/2/2017
18:36
Thanks for this find Waterloo.
callumross
22/2/2017
14:18
Assume this will be of interest to investors here (I'm not one of them). hTtp://files.shareholder.com/downloads/AMDA-2OTJP1/2078936451x0x929087/7B305F8C-A70C-4D08-A197-4E97EF3B6172/Progress_in_RNAi-based_therapeutics.pdf Edit: All looks rather early stage given the recent fail as some patients died. 'Back in trials next year'. A lot of mouths to feed in the 'family' photo at the end. Note this is dated tomorrow!
waterloo01
17/2/2017
08:29
Ah well even if nothing else is happening ,at least our share in arrowhead is gaining !!.
partner
16/2/2017
17:53
Interesting read through here - http://www.dailymail.co.uk/sciencetech/article-4231342/Cancer-inherited-disease-vanish-20-years.html
richie666
Chat Pages: 2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170425 12:33:41